Global Antisense And RNAi Therapeutics Market 2024-2033 | Trends, Growth, and Forecast
The Global Antisense And Rnai Therapeutics Market is experiencing rapid expansion as gene-silencing technologies revolutionize the treatment of previously hard-to-treat and rare diseases. These therapies work at the genetic level, targeting specific disease-causing genes, providing highly precise treatment options that conventional drugs often cannot achieve. The growing focus on personalized medicine, coupled with breakthroughs in delivery methods and molecular design, is driving significant interest from pharmaceutical companies, healthcare providers, and investors alike. Antisense and RNA interference (RNAi) therapies are increasingly recognized for their potential in treating a wide spectrum of diseases, including neurological disorders, metabolic syndromes, cardiovascular conditions, and genetic disorders. With an expanding pipeline of therapeutic candidates, the market is poised for substantial growth in the coming years. The market is projected to reach a valuation of USD 5.5 b...